CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 4 enrolled
Drug / intervention
ketamine in lactationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04285684
NCT04285684Early Ph 1Completed
CompareCT.gov

The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites

The Ketamine Research Foundation·interventional·Posted Feb 26, 2020·Updated Dec 13, 2021

In Brief

A Early Phase 1 clinical trial evaluating ketamine in lactation for Ketamine and Lactation. Completed, enrolled 4 participants across 1 site.

Detailed Summary

Quantification of Ketamine in Breast Milk at 3 hour Intervals up to 30 hours-- obtained from lactating women who receive 2 different Intramuscular injections of ketamine on two separate days at least 5 days apart.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKetamine, Lactation
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedFeb 26, 2020
Enrollment StartDec 20, 2019
Primary CompletionJan 5, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.4 years ago

Interventions

ketamine in lactationdrug

2 dose IM by weight and assessing concentrations of ketamine in expressed milk at intervals